{"title":"Medicines and Treatments for Varicose Veins and Hemorrhoids","description":"\u003cp\u003e Medicines and medical devices for the treatment of venous disorders and hemorrhoids. Oral and topical formulations with diosmin, flavonoids, escin, centella asiatica and zinc oxide. Ideal for reducing inflammation, pain, itching and swelling in cases of internal or external hemorrhoids, varicose veins and heavy legs. Also useful during pregnancy and postpartum. Fast shipping in 24\/48 hours.\u003c\/p\u003e\n\n\u003cp\u003e\u003c\/p\u003e","products":[{"product_id":"gel-fresco-gambe-125ml-dr-tili","title":"Fresh Legs Gel 125ml Dr.Tili ","description":"\u003cp\u003e\u003cimg style=\"float: none;\" height=\"125\" width=\"125\" alt=\"Supplement made in Italy\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Made_in_Italy.png?v=1668012159\" data-mce-style=\"float: none;\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Made_in_Italy.png?v=1668012159\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003cimg data-mce-fragment=\"1\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Privo_di_metalli_pesanti_480x480.png?v=1668012159\" alt=\"monitored heavy metals\" width=\"125\" height=\"125\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Privo_di_metalli_pesanti_480x480.png?v=1668012159\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003cimg data-mce-fragment=\"1\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/nichel_tested_480x480.png?v=1668012159\" alt=\"nickel tested\" width=\"125\" height=\"125\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/nichel_tested_480x480.png?v=1668012159\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003cimg data-mce-fragment=\"1\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/fragrance_free_480x480.png?v=1668012159\" alt=\"without added fragrance\" width=\"125\" height=\"125\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/fragrance_free_480x480.png?v=1668012159\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003cspan\u003e \u003c\/span\u003e\u003cimg data-mce-fragment=\"1\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/senza_parabeni_480x480.png?v=1668012159\" alt=\"without parabens\" width=\"125\" height=\"125\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/senza_parabeni_480x480.png?v=1668012159\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eFresh Legs Gel is a gel based on highly titrated phytotherapeutic extracts of horse chestnut, aloe vera and menthol. It gives an immediate sensation of \u003cstrong\u003eintense cold,\u003c\/strong\u003e indicated to soothe and treat the \u003cstrong\u003eswelling in the legs, a sense of heaviness in the lower limbs \u003c\/strong\u003eand the \u003cstrong\u003elymphatic stagnation and venous stasis\u003c\/strong\u003e. Thanks to its toning action it is also indicated at the end of physical activity \u003cstrong\u003eprevent and soothe muscle fatigue\u003c\/strong\u003e in the recovery phase. Fresh Leg Gel has a fresh, minty fragrance, dries quickly, is not greasy and leaves no residue.\u003c\/p\u003e\n\u003cp\u003eI \u003cstrong\u003ehorse chestnut seeds\u003c\/strong\u003e they are used in phytotherapy for their decongestant, anti-edema and phlebotonic action. They contain a mixture of triterpene saponins (\u003cstrong\u003eexit\u003c\/strong\u003e), coumarins (esculetin),  flavonoids and proanthocyanidins responsible for their properties. Aescin, in particular, is the most important active ingredient and together with flavonoids gives horse chestnut seeds properties \u003cstrong\u003enatural anti-inflammatory, antioxidant and vasoprotective. \u003c\/strong\u003eEscin is particularly useful in case of \u003cstrong\u003eproblems \u003c\/strong\u003erelating to \u003cstrong\u003eblood and lymphatic circulation \u003c\/strong\u003ebecause he is capable of \u003cstrong\u003ereduce the activity of elastase and hyaluronidase. \u003c\/strong\u003eThese two enzymes attack the endothelium of blood vessels and the extracellular matrix, \u003cstrong\u003eweakening its structure\u003c\/strong\u003e. By reducing the activity of these enzymes, \u003cstrong\u003ethe vessels regain normal resistance and permeability\u003c\/strong\u003e. It thus provides relief from the symptoms of venous insufficiency such as a sense of heaviness, swelling and itching in the legs.\u003c\/p\u003e\n\u003cp\u003eThe improvement of the activity of the microcirculation through the normalization of the capillaries \u003cstrong\u003epromotes lymphatic drainage and combats cellulite\u003c\/strong\u003e and capillary fragility.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy should I use Dr.Tili Fresh Leg Gel 125ml? What is it for?\u003c\/h3\u003e\u003cp\u003eGel based on horse chestnut, aloe vera and menthol, with immediate cold effect; helps relieve tired and heavy legs and soothe swelling of the lower limbs. Also indicated after physical activity for muscle recovery.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Dr.Tili Fresh Leg Gel 125ml contain?\u003c\/h3\u003e\u003cp\u003ewater alcohol glycerin, menthol menthyl lactate, phenoxyethanol, ppg-26-buteth-26, peg-40, hydrogenated castor oil aloe barbadensis leaf juice, carbomer, sodium hydroxide, beta-sitosterol, sodium hydroxide, beta-sitosterol, aescin, aesculus hippocastanum extract, secitin.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Dr.Tili Fresh Leg Gel 125ml?\u003c\/h3\u003e\u003cp\u003eApply Fresh Gel on legs and hips. Massage lightly with circular movements until completely absorbed.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Dr.Tili Fresh Leg Gel 125ml?\u003c\/h3\u003e\u003cp\u003eKeep out of reach of children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Dr.Tili Fresh Leg Gel 125ml stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Dr.Tili Fresh Leg Gel 125ml?\u003c\/h3\u003e\u003cp\u003e125ml\u003c\/p\u003e","brand":"Tilab","offers":[{"title":"Default Title","offer_id":40207819407475,"sku":"975044189","price":13.5,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/tilab-srl-gel-fresco-gambe-125ml-dr-tili-farmacia-dottor-tili-1213792893.jpg?v=1767123609"},{"product_id":"proctolyn-crema-rettale-30-g","title":"Proctolyn Rectal Cream 30 g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eInternal and external hemorrhoids; anal and perianal eczema and erythema; anal fissures; anal and perianal itching and burning; pre- and post-operative treatment in anorectal surgery.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eRectal cream\u003c\/i\u003e \u003c\/b\u003e One gram of rectal cream contains 0.1 mg of fluocinolone acetonide and 10 mg of ketocaine hydrochloride (equal to 8.9 mg of ketocaine). Excipients with known effects: One gram of rectal cream contains 1.5 mg of methyl parahydroxybenzoate, 0.5 mg of propyl parahydroxybenzoate, 70 mg of propylene glycol, 50 mg of stearyl alcohol, 50 mg of cetyl alcohol. \u003cb\u003e \u003ci\u003eSuppositories\u003c\/i\u003e \u003c\/b\u003e Each suppository contains 0.1 mg of fluocinolone acetonide and 10 mg of ketocaine hydrochloride (equal to 8.9 mg of ketocaine). Excipient with known effects: Each suppository contains 40 mg of propylene glycol. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eRectal cream\u003c\/i\u003e \u003c\/b\u003e citric acid menthol methyl parahydroxybenzoate propyl parahydroxybenzoate propylene glycol stearyl alcohol cetyl alcohol Vaseline oil sorbitan monostearate polysorbate 60 purified water \u003cb\u003e \u003ci\u003eSuppositories\u003c\/i\u003e \u003c\/b\u003e citric acid menthol propylene glycol polysorbate 60 sorbitan monostearate colloidal silica semi-synthetic glycerides\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. TB, mycosis, Herpes Symplex, viral diseases with skin localization.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eRectal cream\u003c\/i\u003e \u003c\/b\u003e Just enough to cover the affected part, massaging lightly and repeating the application 2-3 times a day. For internal application use the appropriate cannula inserted on the tube. \u003cb\u003e \u003ci\u003eSuppositories\u003c\/i\u003e \u003c\/b\u003e 1 suppository in the morning and 1 in the evening. \u003ci\u003eRectal cream and suppositories can be used for combined treatments\u003c\/i\u003e. \u003ci\u003ePediatric population\u003c\/i\u003e The use of Proctolyn is not recommended in children under 12 years of age, due to a lack of data on safety and efficacy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe topical application of cortisone in excessive doses and for prolonged periods can lead to systemic absorption. The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. In the presence of a skin infection, appropriate coverage therapy should be instituted. \u003cu\u003eVisual disturbances\u003c\/u\u003e Visual disturbances may be reported with the use of systemic and topical corticosteroids. If a patient presents with symptoms such as blurred vision or other visual disturbances, referral to an ophthalmologist should be considered for evaluation of possible causes which may include cataracts, glaucoma, or rare diseases such as central serous chorioretinopathy (CSCR), which have been reported after the use of systemic and topical corticosteroids. \u003cu\u003eImportant information about some excipients\u003c\/u\u003e: Proctolyn rectal cream contains • methyl parahydroxybenzoate and propyl parahydroxybenzoate which may cause allergic reactions (even delayed ones); • stearyl alcohol and cetyl alcohol which can cause localized skin reactions (e.g. contact dermatitis).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConcomitant treatment with CYP3A inhibitors, including cobicistat-containing medicinal products, is thought to increase the risk of systemic side effects. The combination should be avoided unless the benefit outweighs the increased risk of systemic side effects due to corticosteroids; in this case it is necessary to monitor patients to verify the absence of systemic side effects due to corticosteroids.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDuring topical cortisone therapy, especially for intense and prolonged treatments, the following side effects may occur: burning sensation, itching, irritation. Blurred vision may occur (see also section 4.4), with an unknown frequency. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \u003cu\u003ehttp:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetta-reazione-avversa\u003c\/u\u003e.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e Topical administration of corticosteroids during pregnancy in laboratory animals may cause abnormalities in fetal development. There are no adequate data from the use of fluocinolone acetonide in pregnant women. Therefore the medicine must be used only if necessary, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus. \u003cu\u003eBreastfeeding\u003c\/u\u003e When administered systemically, corticosteroids are excreted through breast milk. It is not known whether they are also effective when administered topically. Therefore, topical corticosteroids should be used with caution during breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProctolyn does not affect the ability to drive or use machines.\u003c\/p\u003e","brand":"Recordati","offers":[{"title":"Default Title","offer_id":40207824289907,"sku":"021925060","price":12.74,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/recordati-proctolyn-crema-rettale-30-g-farmacia-dottor-tili-1254215807.jpg?v=1786737489"},{"product_id":"daflon-30-compresse-rivestite-500mg","title":"Daflon 30 Coated Tablets 500mg","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptoms attributable to venous insufficiency; states of capillary fragility. Symptomatic treatment of acute hemorrhoidal crisis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach film-coated tablet contains 500 mg of micronized purified flavonoid fraction consisting of 450 mg of diosmin and 50 mg of flavonoids expressed as hesperidin. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium starch starch, microcrystalline cellulose, gelatin, glycerin, hypromellose, sodium lauryl sulphate, yellow iron oxide E172, red iron oxide E 172, titanium dioxide, macrogol 6000, magnesium stearate, talc.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDosage \u003ci\u003eVenous insufficiency (also of the haemorrhoidal plexus) and capillary fragility \u003c\/i\u003e The recommended dose is 2 tablets to be taken in two doses per day. Do not exceed the maximum daily dose. \u003ci\u003eAcute hemorrhoidal crisis\u003c\/i\u003e The recommended dose is 3 tablets twice a day during the first 4 days of treatment; in the following 3 days the daily dose is 4 tablets in two administrations. Do not exceed the maximum daily dose. Method of administration Take the tablets with the two main meals. Duration of treatment Treatment must not be continued beyond 7 days. In the absence of a therapeutic response, reassess the situation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImportant information about some excipients Daflon contains less than 1 mmol (23 mg) sodium per tablet, i.e. it is essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo interaction studies have been performed. To date, no clinically relevant drug interactions have been reported from post-marketing experience on the product.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following adverse effects or reactions have been reported and are classified according to the following frequency: very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000), not known (frequency cannot be estimated from the available data). \u003ci\u003eNervous system disorders\u003c\/i\u003e Rare: dizziness, headache, malaise \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e Common: diarrhoea, dyspepsia, nausea, vomiting Uncommon: colitis Not known: abdominal pain \u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e Rare: rash, pruritus, urticaria Not known: edema of the face, lips, eyelid; Quincke's edema \u003ci\u003ePathologies of the blood and lymphatic system\u003c\/i\u003e Not known: thrombocytopenia \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the risk\/benefit ratio of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSymptoms\u003c\/u\u003e There is limited experience with Daflon overdose. The most frequently reported adverse events in cases of overdose were gastrointestinal events (such as diarrhea, nausea, abdominal pain) and skin events (such as pruritus, rash). \u003cu\u003eManagement\u003c\/u\u003e Management of overdose should consist of treatment of clinical symptoms.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e Data relating to the use of purified micronized flavonoid fraction in pregnant women do not exist or are limited in number. Animal studies do not indicate reproductive toxicity (see section 5.3). As a precaution, it is preferable to avoid the use of Daflon during pregnancy. \u003cu\u003eBreastfeeding\u003c\/u\u003e It is not known whether the active substance\/metabolites are excreted in breast milk. A risk to the newborn\/infants cannot be excluded. A decision must be made whether to discontinue breast-feeding or to discontinue\/abstain from Daflon therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman. \u003cu\u003eFertility\u003c\/u\u003e Reproductive toxicity studies have shown no effects on fertility in either male or female rats (see section 5.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo studies have been conducted to evaluate the effect of the flavonoid fraction on the ability to drive or use machinery.\u003c\/p\u003e","brand":"Servier","offers":[{"title":"Default Title","offer_id":40207839920243,"sku":"023356025","price":16.55,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/servier-italia-spa-daflon-30-compresse-rivestite-500mg-farmacia-dottor-tili-1213792983.webp?v=1767129769"},{"product_id":"benuscler-crema-100ml","title":"Benuscler Cream 100ml","description":"\u003cp\u003e\u003cspan\u003eBenuscler Cream is a phytocomplex that acts as \u003cstrong\u003edecongestant\u003c\/strong\u003e, \u003cstrong\u003edraining\u003c\/strong\u003e, refreshing, \u003cstrong\u003eanti-inflammatory\u003c\/strong\u003e, \u003cstrong\u003ehealing\u003c\/strong\u003e, similar cortison without rebaund effect. Thanks to the presence of its extracts, Benuscler has a direct action on the epidermal microcirculation, acting on the permeability of the capillary, on redness, on hydration and on the re-epithelisation of the epidermis. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe phytocomplexes present in Benuscler are Panthenol, Chitosans, alpha bisabol, Aloe, Horse Chestnut and green tea. They carry out an effective antioxidant and anti-radical action, maintaining the \u003cstrong\u003enatural hydrolipidic balance of the skin\u003c\/strong\u003e. They also have properties \u003c\/span\u003e\u003cspan\u003eanti-inflammatory, bacteriostatic, soothing, healing, hydrating, anti-inflammatory, antioxidant and vasoconstrictor.\u003cbr\u003e\u003cbr\u003eBenuscler Cream 100ml finds application in case of \u003cstrong\u003es\u003c\/strong\u003e\u003c\/span\u003e\u003cstrong\u003einflammatory and irritative vulvo-vaginal conditions\u003c\/strong\u003e, hemorrhoids, breast fissures, anal and vaginal itching.\u003c\/p\u003e\n\u003cp\u003eThanks to its high hydrating power, Benuscler Cream 100ml is excellent for counteracting \u003cstrong\u003edryness of the skin\u003c\/strong\u003e and mucous membranes. The vasoprotective, anti-inflammatory, anti-redness effect is also indicated in the treatment of \u003cstrong\u003eanal fissures, external hemorrhoids\u003c\/strong\u003e and with the nozzle supplied also for the \u003cstrong\u003einternal hemorrhoids\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIt counteracts the formation of keloids and promotes the healing and re-epithelization of skin lesions.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Benuscler Cream 100ml used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on phytocomplexes (panthenol, chitosan, alpha bisabolol, aloe, horse chestnut and green tea), indicated for the relief of inflammatory and irritative states at the vulvo-vaginal level, hemorrhoids and breast fissures; has a soothing, decongestant and protective action on the skin.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Benuscler Cream 100ml contain?\u003c\/h3\u003e\u003cp\u003eHorse chestnut, green tea, chamomile, yarrow, chitosan, panthenol, aloe, allantoin, soy, 18 beta glycyrrhetinic acid.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Benuscler Cream 100ml?\u003c\/h3\u003e\u003cp\u003eApply and massage the product until completely absorbed. Repeat the application several times a day.\u003cbr\u003eHemorrhoids: apply before evacuation to obtain an emulsifying and protective effect, after evacuation for a decongestant, anti-inflammatory and healing effect.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Benuscler Cream 100ml stored?\u003c\/h3\u003e\u003cp\u003eValidity with intact packaging: 24 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Benuscler Cream 100ml?\u003c\/h3\u003e\u003cp\u003e50 and 100 ml tube.\u003c\/p\u003e","brand":"Dr. Levi","offers":[{"title":"Default Title","offer_id":40207840837747,"sku":"900958695","price":18.62,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/dr-levi-benuscler-crema-100ml-farmacia-dottor-tili-1258975900.jpg?v=1789562171"},{"product_id":"ruscoroid-1-1-crema-40gr","title":"Ruscoroid 1% + 1% Cream 40gr","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment of symptoms associated with hemorrhoids, anal fissures and proctitis, such as: itching, pain and feeling of weight.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of cream contains: Ruscogenin 1 g Tetracaine hydrochloride 1 g Excipients with known effects: cetyl alcohol, methyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate, Rosemary 7144 perfume. For the complete list of excipients, see paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCetyl alcohol, polysorbate 80, macrogol 400, macrogol 4000, methyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate, Rosemary 7144* perfume, purified water. *Rosemary 7144 perfume contains the following allergens: amyl cinnamale, amylcinnamal alcohol, benzyl benzoate, citral, citronellol, coumarin, eugenol, geraniol, hexylcinnamale, hydroxycitronellal, d-limonene, linalool (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active ingredient or to any of the excipients listed in paragraph 6.1 or to other closely related substances from a chemical point of view.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDosage 1 - 2 applications per day Do not exceed the recommended doses. Method of administration Apply directly or using the appropriate applicator.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore below 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not use for prolonged treatments. After a short period of treatment without appreciable results and in case of prolonged use, consult your doctor. The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena; if this happens, treatment should be stopped and the doctor should be consulted to adopt suitable therapeutic measures. Clinical use has not highlighted the need for particular precautions for the use of Ruscoroid. Use under 12 years of age is not recommended, unless under direct medical supervision. \u003cb\u003eRuscoroid 10 mg\/g + 10 mg\/g cream contains cetyl alcohol\u003c\/b\u003e May cause localized skin reactions (e.g. contact dermatitis). \u003cb\u003eRuscoroid 10 mg\/g + 10 mg\/g cream contains methyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate\u003c\/b\u003e They can cause allergic reactions (even delayed). \u003cb\u003eRuscoroid 10 mg\/g + 10 mg\/g cream contains Rosemary 7144 perfume\u003c\/b\u003e This medicine contains a flavoring (Rosemary 7144 perfume) which itself contains allergens which may cause allergic reactions. For the complete composition of allergens see paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePhenomena referable to interaction with other substances have never been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRare cases of sensitization, such as local and generalized erythema associated with itching. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known cases of overdose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe product should be used in cases of actual necessity under direct medical supervision.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRuscoroid does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Vemedia","offers":[{"title":"Default Title","offer_id":40207840936051,"sku":"025825023","price":12.09,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/vemedia-ruscoroid-1-1-crema-40gr-farmacia-dottor-tili-1254215793.jpg?v=1786737070"},{"product_id":"daflon-60-compresse-rivestite-500mg","title":"Daflon 60 Coated Tablets 500mg","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptoms attributable to venous insufficiency; states of capillary fragility. Symptomatic treatment of acute hemorrhoidal crisis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach film-coated tablet contains 500 mg of micronized purified flavonoid fraction consisting of 450 mg of diosmin and 50 mg of flavonoids expressed as hesperidin. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium starch starch, microcrystalline cellulose, gelatin, glycerin, hypromellose, sodium lauryl sulphate, yellow iron oxide E172, red iron oxide E 172, titanium dioxide, macrogol 6000, magnesium stearate, talc.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDosage \u003ci\u003eVenous insufficiency (also of the haemorrhoidal plexus) and capillary fragility \u003c\/i\u003e The recommended dose is 2 tablets to be taken in two doses per day. Do not exceed the maximum daily dose. \u003ci\u003eAcute hemorrhoidal crisis\u003c\/i\u003e The recommended dose is 3 tablets twice a day during the first 4 days of treatment; in the following 3 days the daily dose is 4 tablets in two administrations. Do not exceed the maximum daily dose. Method of administration Take the tablets with the two main meals. Duration of treatment Treatment must not be continued beyond 7 days. In the absence of a therapeutic response, reassess the situation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImportant information about some excipients Daflon contains less than 1 mmol (23 mg) sodium per tablet, i.e. it is essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo interaction studies have been performed. To date, no clinically relevant drug interactions have been reported from post-marketing experience on the product.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following adverse effects or reactions have been reported and are classified according to the following frequency: very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000), not known (frequency cannot be estimated from the available data). \u003ci\u003eNervous system disorders\u003c\/i\u003e Rare: dizziness, headache, malaise \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e Common: diarrhoea, dyspepsia, nausea, vomiting Uncommon: colitis Not known: abdominal pain \u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e Rare: rash, pruritus, urticaria Not known: edema of the face, lips, eyelid; Quincke's edema \u003ci\u003ePathologies of the blood and lymphatic system\u003c\/i\u003e Not known: thrombocytopenia \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the risk\/benefit ratio of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSymptoms\u003c\/u\u003e There is limited experience with Daflon overdose. The most frequently reported adverse events in cases of overdose were gastrointestinal events (such as diarrhea, nausea, abdominal pain) and skin events (such as pruritus, rash). \u003cu\u003eManagement\u003c\/u\u003e Management of overdose should consist of treatment of clinical symptoms.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e Data relating to the use of purified micronized flavonoid fraction in pregnant women do not exist or are limited in number. Animal studies do not indicate reproductive toxicity (see section 5.3). As a precaution, it is preferable to avoid the use of Daflon during pregnancy. \u003cu\u003eBreastfeeding\u003c\/u\u003e It is not known whether the active substance\/metabolites are excreted in breast milk. A risk to the newborn\/infants cannot be excluded. A decision must be made whether to discontinue breast-feeding or to discontinue\/abstain from Daflon therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman. \u003cu\u003eFertility\u003c\/u\u003e Reproductive toxicity studies have shown no effects on fertility in either male or female rats (see section 5.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo studies have been conducted to evaluate the effect of the flavonoid fraction on the ability to drive or use machinery.\u003c\/p\u003e","brand":"Servier","offers":[{"title":"Default Title","offer_id":46656001868103,"sku":"023356049","price":27.71,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/servier-italia-spa-daflon-60-compresse-rivestite-500mg-farmacia-dottor-tili-1213792490.webp?v=1767112538"},{"product_id":"proctosedyl-crema-rettale-20g","title":"Proctosedyl rectal cream 20g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of hemorrhoids, internal or external, especially in the inflammatory phases. Anal itching.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eProctosedyl rectal cream\u003c\/i\u003e: 100 g of rectal cream contains: hydrocortisone acetate 1 g, amylein 1 g, benzocaine 1 g, aesculin 1 g, benzalkonium chloride 5 mg. \u003cu\u003eExcipients with known effect:\u003c\/u\u003e Propylene glycol. For the full list of excipients, see section 6.1. \u003ci\u003eProctosedyl suppositories\u003c\/i\u003e: Each suppository contains: hydrocortisone acetate 5 mg, benzocaine 50 mg, esculin 10 mg, benzalkonium chloride 0.1 mg. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eRectal cream:\u003c\/i\u003e cholesterin, liquid paraffin, macrogol 300, macrogol 1540, macrogol 4000, polysorbate 80, propylene glycol, talc, white petrolatum, purified water. \u003ci\u003eSuppositories\u003c\/i\u003e: medium chain glycerides, solid semisitetic glycerides (Witepsol E85, Witepsol H15).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active ingredients or to any of the excipients and in particular to benzocaine (and other anesthetics with a similar chemical structure) and to substances containing the para group (sulphonamides, promethazine, etc.); tuberculous and viral infections in the area to be treated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eRectal cream\u003c\/u\u003e: For endorectal and perianal applications. Apply the ointment 2 times a day in acute forms; subsequently space out the applications, depending on the evolution of the symptoms.\u003cu\u003eSuppositories\u003c\/u\u003e: 1-2 suppositories per day. Use only for short treatment periods.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRectal cream: do not store above 25°C. Suppositories: this medicine does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUse the minimum effective dosage. Clinical cases suggest that the administration of products containing benzocaine may cause methemoglobinemia attributable to excessive absorption of benzocaine, particularly in children and the elderly. Symptoms such as cyanosis (pallor, greyish or bluish discoloration of the skin, lips and nail beds), headache, dizziness, dyspnoea (shortness of breath), fatigue and tachycardia occurring during treatment may indicate potentially life-threatening methaemoglobinaemia and require immediate medical attention (see section 4.9). Topical application of corticosteroids in excessive doses and for prolonged periods can give rise to generalized reactions due to systemic absorption (Cushing's syndrome, inhibition of the pituitary-adrenal axis). Therefore, once a favorable clinical effect has been obtained, it is necessary to reduce the frequency of application and dosage to a minimum, discontinuing the product as soon as possible. It is in any case necessary to limit the use of topical steroids to short periods of time. Furthermore, use with appropriate caution in subjects with damaged mucous membranes which could cause excessive absorption of the active ingredients. Corticosteroids can be applied to infected areas only if preceded or accompanied by suitable antibacterial or antifungal therapy. In case of failure of the therapy it is necessary to suspend the treatment and adequately treat the infection with other measures. \u003cu\u003e \u003cb\u003eRectal cream\u003c\/b\u003e \u003c\/u\u003e: This medicine contains 5 mg of benzalkonium chloride per 100 g of rectal cream. Benzalkonium chloride may cause local irritation. This medicine contains 2.4 g of propylene glycol per 20 g of rectal cream. May cause skin irritation. Do not use this medicine in children younger than 4 weeks of age with open wounds or large areas of damaged skin (such as burns) without talking to their doctor or pharmacist. \u003cu\u003e \u003cb\u003eSuppositories\u003c\/b\u003e \u003c\/u\u003e: Benzalkonium chloride may cause local irritation. \u003cu\u003e \u003cb\u003eVisual disturbances\u003c\/b\u003e \u003c\/u\u003e: Visual disturbances may be reported with the use of systemic and topical corticosteroids. If a patient presents with symptoms such as blurred vision or other visual disturbances, referral to an ophthalmologist should be considered for evaluation of possible causes, which may include cataracts, glaucoma, or rare diseases such as central serous chorioretinopathy (CSCR), which have been reported after the use of systemic and topical corticosteroids.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo interaction studies have been performed. Concomitant treatment with CYP3A inhibitors, including cobicistat-containing medicinal products, is thought to increase the risk of systemic side effects. The combination should be avoided unless the benefit outweighs the increased risk of systemic side effects due to corticosteroids; in this case it is necessary to monitor patients to verify the absence of systemic side effects due to corticosteroids.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUndesirable effects are classified according to MedDRA System Organ Terminology. \u003cb\u003eSystemic disorders and conditions relating to the administration site:\u003c\/b\u003e Hypersensitivity reactions with edema, redness, itching may occur locally. \u003cu\u003e \u003cb\u003eEye pathologies.\u003c\/b\u003e \u003c\/u\u003e \u003cb\u003eFrequency not known (frequency cannot be estimated from the available data)\u003c\/b\u003e \u003cu\u003e: vision, blurred (see also section 4.4)\u003c\/u\u003e \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e. Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system of the Italian Medicines Agency at: \u003cu\u003ehttps:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/u\u003e.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe phenomena caused by excess corticosteroids are characterized by asthenia, adynamia, arterial hypertension, edema, cardiac rhythm disorders, hypokalemia, metabolic alkalosis. Case reports suggest that administration of benzocaine-containing products may cause methemoglobinemia. Symptoms such as cyanosis (pallor, greyish or bluish discoloration of the skin, lips and nail beds), headache, dizziness, dyspnea (shortness of breath), fatigue and tachycardia that occur during treatment may indicate potentially life-threatening methemoglobinemia and require immediate medical attention. The recommended treatment includes, in addition to supportive therapy, intravenous infusion of methylene blue.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDuring pregnancy and\/or breastfeeding the medicine must be used only if necessary, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProctosedyl does not affect the ability to drive or use machines.\u003c\/p\u003e","brand":"Karo Healthcare","offers":[{"title":"Default Title","offer_id":51131208466759,"sku":"013868031","price":12.28,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/karo-healthcare-ab-proctosedyl-crema-rettale-20g-farmacia-dottor-tili-1213792365.jpg?v=1767142489"},{"product_id":"proctosoll-crema-rettale-30g-con-cannula-erogatrice","title":"Proctosoll rectal cream 30g with dispensing cannula","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of uncomplicated external hemorrhoids.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100g of \u003ci\u003ecream\u003c\/i\u003e contain: - BENZOCAINE g: 5; - HYDROCORTISONE ACETATE g: 0.5; - SODIUM HEPARIN IU: 5,000. \u003ci\u003eFor excipients, see 6.1.\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCetostearyl alcohol, isopropyl myristate, propylene glycol, macrogol cetostearyl ether, dimethicone, isothiazolinone, levomenthol, disodium EDTA, butylated hydroxyanisole, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity towards components or other substances closely related from a chemical point of view. Tuberculous skin lesions. Viral infections.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn acute forms, particularly after evacuation, apply the cream 2-3 times a day. Do not exceed the recommended doses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore at a temperature not exceeding 30° C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAfter a short period of treatment, without appreciable results, consult your doctor. Excessive and\/or prolonged application of cortisone can give rise to generalized reactions due to systemic absorption. The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. In this case it is necessary to interrupt treatment and institute suitable therapy. The effectiveness and safety of benzocaine depend on correct dosage; it is therefore necessary to use the minimum quantity of the preparation sufficient to obtain the desired effect by applying it with caution in subjects with seriously damaged mucous membranes or the site of inflammatory processes which could cause excessive absorption of the active ingredient. High absorption of benzocaine can cause serious reactions, particularly in children and elderly patients. Proctosoll contains propylene glycol This medicinal product contains 25 mg of propylene glycol per dose equivalent to 25 mg\/g. Proctosoll contains butylated hydroxyanisole. May cause localized skin reactions (e.g. contact dermatitis) or irritation of the eyes and mucous membranes. Proctosoll contains cetostearyl alcohol. May cause localized skin reactions (e.g. contact dermatitis). Keep the medicine out of the reach of children.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eParticular attention must be paid to its use in conjunction with other anticoagulant treatments.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLocally, burning sensation, irritation, dryness of the skin, folliculitis, acne eruptions, hypertrichosis, hyperpigmentation and skin atrophy may sometimes occur. If any local reaction typical of corticotherapy appears, it can be remedied by suspending the treatment.\u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known symptoms of overdose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn pregnant women, use must be carried out only in case of actual need and under the direct supervision of a doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe product does not interfere with the ability to drive and use machines.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51131221967175,"sku":"027377023","price":12.93,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-proctosoll-crema-rettale-30g-con-cannula-erogatrice-farmacia-dottor-tili-1213792348.jpg?v=1767142749"},{"product_id":"essaven-10mg-g-8mg-g-gel-80g","title":"Essaven 10mg\/g + 8mg\/g gel 80g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptoms attributable to venous insufficiency; states of capillary fragility.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g contain: Active ingredients: Escin 1 g Phosphatidylcholine 0.8 g For the complete list of excipients, see paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIsopropanol, glycerol, triethanolamine, carbopol 940, cologne, rosemary essence, lavender essence, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients. Essaven must not be spread on open skin wounds, eczema and mucous membranes (anal, etc.).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eApply the preparation 3 times a day, spreading on the painful and swollen regions, evenly distributing the gel until absorbed, even on the surrounding parts, without the need to massage. Do not exceed the recommended doses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eKeep away from heat sources.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAvoid contact with eyes. For external use only. The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. If this occurs, discontinue treatment and institute appropriate therapy. After a short period of treatment without appreciable results, consult your doctor. Keep the medicine out of the reach and sight of children.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo notes so far.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn very rare cases, allergic reactions may occur, such as exanthema or rash and urticaria. Itching (frequency not known). Any skin redness, which is extremely rare, disappears spontaneously when the application of the preparation is suspended.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use of the preparation in cases of pregnancy and breastfeeding is not contraindicated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEssaven does not alter the ability to drive or use machines.\u003c\/p\u003e","brand":"Vemedia","offers":[{"title":"Default Title","offer_id":51131285176647,"sku":"036193023","price":15.81,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/vemedia-manufacturing-b-v-essaven-10mg-g-8mg-g-gel-80g-farmacia-dottor-tili-1213792238.jpg?v=1767133967"},{"product_id":"essaven-10mg-g-8mg-g-gel-40g","title":"Essaven 10mg\/g + 8mg\/g gel 40g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptoms attributable to venous insufficiency; states of capillary fragility.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g contain: Active ingredients: Escin 1 g Phosphatidylcholine 0.8 g For the complete list of excipients, see paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIsopropanol, glycerol, triethanolamine, carbopol 940, cologne, rosemary essence, lavender essence, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients. Essaven must not be spread on open skin wounds, eczema and mucous membranes (anal, etc.).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eApply the preparation 3 times a day, spreading on the painful and swollen regions, evenly distributing the gel until absorbed, even on the surrounding parts, without the need to massage. Do not exceed the recommended doses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eKeep away from heat sources.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAvoid contact with eyes. For external use only. The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. If this occurs, discontinue treatment and institute appropriate therapy. After a short period of treatment without appreciable results, consult your doctor. Keep the medicine out of the reach and sight of children.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo notes so far.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn very rare cases, allergic reactions may occur, such as exanthema or rash and urticaria. Itching (frequency not known). Any skin redness, which is extremely rare, disappears spontaneously when the application of the preparation is suspended.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use of the preparation in cases of pregnancy and breastfeeding is not contraindicated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEssaven does not alter the ability to drive or use machines.\u003c\/p\u003e","brand":"Vemedia","offers":[{"title":"Default Title","offer_id":51131300020551,"sku":"036193011","price":10.22,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/vemedia-manufacturing-b-v-essaven-10mg-g-8mg-g-gel-40g-farmacia-dottor-tili-1213792187.jpg?v=1767127213"},{"product_id":"preparazione-h-1-08-unguento-25g","title":"Preparation H 1.08% ointment 25g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUncomplicated external and internal hemorrhoids and anal fissures.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003e10.8 mg\/g ointment\u003c\/u\u003e 100 g of ointment contain: Active ingredient: Saccharomyces Cerevisiae cell extract 1.08 g. Excipients with known effects: lanolin, butylated hydroxytoluene (BHT), methyl parahydroxybenzoate, propyl parahydroxybenzoate. For the full list of excipients, see section 6.1. \u003cu\u003e23 mg suppositories\u003c\/u\u003e Each suppository contains: Active ingredient: Saccharomyces Cerevisiae cell extract 23 mg. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eOINTMENT\u003c\/u\u003e: shark liver oil; white petrolatum; light mineral oil; Argobase L2 (liquid paraffin, wool wax, petrolatum, anhydrous lanolin, ozokerite, butylated hydroxytoluene (BHT)); lanolin; glycerol; methyl-p-hydroxybenzoate; propyl-p-hydroxybenzoate; red thyme oil. \u003cu\u003eSUPPOSITORY\u003c\/u\u003e: shark liver oil, Witepsol W35, cocoa butter, parawax, polyethylene glycol dilaurate 600, glycerol.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active ingredient or to closely chemically related substances, or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eOINTMENT (tube)\u003c\/u\u003e: apply the ointment up to 2-3 times a day, when possible, after each bowel movement. For rectal use, remove the cap, lubricate the applicator and screw it onto the tube. Squeeze until the applicator is filled. Insert into the rectum, squeeze the tube again until a sufficient quantity of product is introduced. Apply the ointment also on the external area. After use, clean the applicator and cover it with the cap. \u003cu\u003eOINTMENT (single dose)\u003c\/u\u003e: apply the entire contents up to 2-3 times a day, when possible, after each bowel movement. Remove the cap, insert the applicator into the rectum, squeeze the entire contents of the single-dose tube. \u003cu\u003eSUPPOSITORY\u003c\/u\u003e: remove the protective cover and introduce up to 2-3 suppositories a day into the rectum, when possible, after each bowel movement. DO NOT EXCEED THE RECOMMENDED DOSES.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eOintment\u003c\/i\u003e: Store at temperatures not exceeding 25°C. \u003ci\u003eSuppositories\u003c\/i\u003e: Store at temperatures not exceeding 30°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAfter a short period of treatment without appreciable results, consult your doctor. The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. In this case it is necessary to interrupt treatment and institute suitable therapy, after consulting your doctor. In case of bleeding or the persistence of the disorder, consult your doctor. DO NOT USE FOR PROTRACT TREATMENTS. \u003cb\u003ePreparation H ointment contains lanolin\u003c\/b\u003e, which can cause local skin reactions (e.g. contact dermatitis).\u003cb\u003ePreparation H ointment contains butylated hydroxytoluene\u003c\/b\u003e, which may cause local skin reactions (e.g. contact dermatitis) or irritation of the eyes and mucous membranes. \u003cb\u003ePreparation H ointment contains methyl parahydroxybenzoate and propyl parahydroxybenzoate\u003c\/b\u003e which can cause allergic reactions (even delayed).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProblems related to interaction with other drugs have never been highlighted.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo side effects have been reported due to the use of Preparation H. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system at www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo overdose phenomena have been reported with the use of Preparation H.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no contraindications if the product is used following the suggested methods and precautions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo effects on the ability to drive or use machines have been reported after use of Preparation H.\u003c\/p\u003e","brand":"Haleon","offers":[{"title":"Default Title","offer_id":51131350090055,"sku":"017389091","price":12.6,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/haleon-italy-srl-preparazione-h-1-08-unguento-25g-farmacia-dottor-tili-1213791973.jpg?v=1767149926"},{"product_id":"anonet-plus-crema-30g","title":"Anonet Plus cream 30g","description":"\u003cp\u003e\u003cstrong\u003eAnonet Plus cream 30g\u003c\/strong\u003e is an advanced emollient treatment, designed to offer immediate and long-lasting relief from itching, burning and discomfort in the anal and perianal area, both male and female. Thanks to its formulation rich in \u003cstrong\u003ebioactive phytoextracts\u003c\/strong\u003e of mallow, calendula and wintergreen, this soothing and refreshing cream works quickly to calm irritated and hypersensitive skin.\u003c\/p\u003e\n\n\u003cp\u003eThe presence of \u003cstrong\u003ezinc oxide\u003c\/strong\u003e e \u003cstrong\u003esweet almond oil\u003c\/strong\u003e creates a protective layer that strengthens and restores the skin's natural defenses, helping to restore the altered skin barrier. The extracts of \u003cstrong\u003ehorse chestnut\u003c\/strong\u003e, \u003cstrong\u003eHamamelis\u003c\/strong\u003e e \u003cstrong\u003eCentella\u003c\/strong\u003e they work synergistically to relieve sensations of discomfort, improving the microcirculation of the treated area.\u003c\/p\u003e\n\n\u003cp\u003eAnonet Plus cream is formulated not to be greasy, not to stain and not to leave unpleasant odors, making it ideal for daily use. Its effectiveness is further enhanced by the presence of oils of vegetable origin, which not only soothe but also lubricate, facilitating evacuation. This product is perfect for those looking for a \u003cstrong\u003eimmediate relief\u003c\/strong\u003e and long-lasting protection for the sensitive skin of the anal and perianal area.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Anonet Plus cream 30g used? What is it for?\u003c\/h3\u003e\u003cp\u003eEmollient and soothing cosmetic cream based on mallow, calendula and wintergreen phytoextracts, zinc oxide and sweet almond oil, designed for the skin of the anal and perianal area subject to itching, burning and discomfort; helps soothe irritation and maintain the skin barrier, without being greasy or staining.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Anonet Plus cream 30g contain?\u003c\/h3\u003e\u003cp\u003eAqua, Propylene Glycol, Cyclopentaiutoxane, Zinc Oxide, Decyl Oleate, Oryza Sativa Starch, Ceresin, Cetyl PEG\/PPG-10\/1 Dimethicone, Paraffinum Liquidum, Prunus Amygdalus Dulcis Oil, Sodium Chloride, Gadi Iecur Oil, Hydrogenated Castor Oil, Magnesium Oxide, Titanium Dioxide, Bismuth Subnitrate, Aloe Barbadensis Leaf Juice Powder, Dipotassium Glycyrrhizate, Aesculus Hippocastanum Seed Extract, Hamamelis Virginiana Leaf Extract, Calendula Officinalis Flower Extract, Centella Asiatica Extract, Glucose, Triticum Vulgare Germ Oil, Gaultheria Procumbens Leaf Oil, BHT, Pelargonium Graveolens Flower Oil, Cyclohexaiutoxane, Isopropyl Myristate, Sodium Dehydroacetate, Sodium Methylparaben, Sorbic Acid, Lecithin, Citronellol, Escin, Tetrasodium EDTA, Geraniol, Tocopheryl Acetate, Linalool, Eucalyptol.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Anonet Plus cream 30g?\u003c\/h3\u003e\u003cp\u003eThoroughly cleanse the area to be treated. Use Anonet Plus morning and evening and after each bowel movement, with a light massage directly on the affected area.\u003cbr\u003eThoroughly cleanse your hands and the area to be treated before use.\u003cbr\u003e- For external use\u003cbr\u003eOpen the tube, remove the warranty seal and use a quantity of cream sufficient to cover the affected part.\u003cbr\u003e- For internal use\u003cbr\u003eFor internal use, open the tube, remove the guarantee seal, insert the applicator contained in the package and use a quantity of cream sufficient to cover the affected part.\u003cbr\u003eAfter use, remove the applicator, wash it carefully and store it in a clean place away from dust.\u003cbr\u003eDo not rinse the treated area.\u003cbr\u003eClose.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Anonet Plus cream 30g?\u003c\/h3\u003e\u003cp\u003ePost-opening validity: 12 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Anonet Plus cream 30g stored?\u003c\/h3\u003e\u003cp\u003ePost-opening validity: 12 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Anonet Plus cream 30g?\u003c\/h3\u003e\u003cp\u003e30ml.\u003c\/p\u003e","brand":"Uniderm","offers":[{"title":"Default Title","offer_id":51131351204167,"sku":"906607914","price":15.39,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/uniderm-farmaceutici-srl-anonet-plus-crema-30g-farmacia-dottor-tili-1213791969.jpg?v=1767149968"},{"product_id":"venoruton-500mg-30-compresse-rivestite","title":"Venoruton 500mg 30 coated tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVENORUTON is indicated in the treatment of symptoms related to venous insufficiency; states of capillary fragility.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eVenoruton 1000 mg powder\u003c\/u\u003e: One sachet contains - Active ingredient: oxerutin 1000 mg. \u003cu\u003eVenoruton 500 mg coated tablets\u003c\/u\u003e: One tablet contains: Active ingredient oxerutin 500 mg. Excipients with known effects: sunset yellow aluminum lake (E 110) (2.68 mg\/tablet). \u003cu\u003eVenoruton 2% gel\u003c\/u\u003e: 100 g of gel contains: Active ingredient oxerutin 2 g. Excipients with known effects: benzalkonium chloride 0.05 mg\/g. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eVenoruton 1000 mg powder\u003c\/u\u003e: mannitol; sodium saccharin; citric acid monohydrate. \u003cu\u003eVenoruton 500 mg coated tablets\u003c\/u\u003e: polyacrylate dispersion 30 percent; talc; magnesium stearate; macrogoli; copovidone; \u003cb\u003esunset yellow aluminum lacquer (E 110)\u003c\/b\u003e; titanium dioxide. \u003cu\u003eVenoruton 2% gel for cutaneous use:\u003c\/u\u003e carbomers; sodium hydroxide; disodium edetate; \u003cb\u003ebenzalkonium chloride\u003c\/b\u003e; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eVenoruton 1000 mg powder\u003c\/u\u003e: 2 to 3 sachets per day, depending on the severity of the symptom. The contents of each sachet of powder should be carefully dissolved in a little water and taken before or during meals, even in venous insufficiency of the hemorrhoidal plexus. \u003cu\u003eVenoruton 500 mg coated tablets\u003c\/u\u003e: 2 - 3 tablets per day. The tablets should be swallowed whole with a little water, without chewing, before or during meals, even in venous insufficiency of the haemorrhoidal plexus. \u003cu\u003eVenoruton 2% gel for cutaneous use\u003c\/u\u003e: apply an adequate quantity of gel both on the area affected by the disorder and on the surrounding areas, 2 times a day (morning and evening). Massage lightly to allow the medicine to penetrate until completely absorbed, that is, until the skin feels dry upon contact with your hands. Do not exceed the recommended doses. Use only for short treatment periods.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePatients suffering from lower limb edema due to heart, kidney or liver disease should not take Venoruton as the effect of Venoruton is not demonstrated in these indications. Pediatric population The use of Venoruton is not recommended in children. \u003cu\u003eVenoruton gel\u003c\/u\u003e: The use, especially if prolonged, of products to be applied to the skin can give rise to sensitization phenomena. In this case you should stop treatment and contact your doctor to institute suitable therapy. \u003cb\u003e \u003ci\u003eImportant information about some excipients\u003c\/i\u003e \u003c\/b\u003e Venoruton 1000 mg powder contains: - sodium saccharin: this medicinal product contains less than 1 mmol (23 mg) sodium per dose, i.e. essentially 'sodium-free'. Venoruton 500 mg film-coated tablets contain the azo coloring agent: - sunset yellow aluminum lake (E 110): may cause allergic reactions. Venoruton gel contains: - benzalkonium chloride: this medicinal product contains 0.391 mg of benzalkonium chloride per dose equivalent to 0.05 mg\/g. Benzalkonium chloride may irritate the skin. If you are breastfeeding, do not apply this medicine to your breasts because your baby may ingest it with his milk.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo date, no specific interaction of oxerutin with other medicinal products has been reported. In vitro data on a possible modulation of CYP3A activity by oxerutin components (quercetin and rutin present in trace amounts) are conflicting. Venoruton gel: no interactions with medicinal products have been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVenoruton oral formulations: \u003cb\u003eSafety profile summary \u003c\/b\u003e Venoruton may in rare cases cause gastrointestinal side effects or skin reactions such as gastrointestinal disorders, flatulence, diarrhoea, abdominal pain, stomach discomfort, dyspepsia, rash, itching or hives. Very rare is the appearance of dizziness, headache, hot flashes, tiredness or hypersensitivity reactions such as anaphylactoid reactions. \u003cb\u003eTable of adverse reactions \u003c\/b\u003e Side effects are listed below by system organ class and frequency. Frequencies are defined as: very common (≥ 1\/10), common (≥ 1\/100 to \u003c 1\/10); uncommon (≥ 1\/1,000 to \u003c 1\/100); rare (≥ 1\/10,000 to \u003c 1,000); very rare (\u003c 1\/10,000), or not known (frequency cannot be estimated from the available data). Within each frequency class, undesirable effects are indicated in order of decreasing seriousness.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Anaphylactoid reactions.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Hypersensitivity reactions\u003c\/p\u003e\n\u003cp\u003eNervous system disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Dizziness.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Headache.\u003c\/p\u003e\n\u003cp\u003eVascular pathologies.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Flushing.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Gastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Flatulence.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Diarrhoea.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Abdominal pain.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Stomach disorders.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Dyspepsia.\u003c\/p\u003e\n\u003cp\u003ePathologies of the skin and subcutaneous tissue.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Rash.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Pruritus.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Urticaria.\u003c\/p\u003e\n\u003cp\u003eSystemic pathologies and conditions relating to the administration site.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Tiredness.\u003c\/p\u003e\n\u003cp\u003eVenoruton gel: \u003cb\u003eSafety profile summary\u003c\/b\u003e Venoruton gel is well tolerated. Rare cases of sensitization with the appearance of skin reactions have been observed. These symptoms disappear when treatment is stopped. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo case of overdose has ever been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e The safety of the drug in pregnancy has not been determined, therefore it is not recommended during pregnancy. \u003cu\u003eBreastfeeding\u003c\/u\u003e In animal studies, traces of oxerutin have been found in breast milk. It is assumed that the small quantities of oxerutin that pass into breast milk can be considered to have no clinical relevance for humans. \u003cu\u003eFertility\u003c\/u\u003e Animal studies have shown no effects on fertility after administration of oxerutin.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVenoruton has no or negligible influence on the ability to drive or use machines. In rare cases, tiredness and dizziness have been reported in patients taking the product. Affected patients are advised not to drive or use machinery. Venoruton gel does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Eg","offers":[{"title":"Default Title","offer_id":51131360248135,"sku":"017076148","price":16.34,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/eg-spa-venoruton-500mg-30-compresse-rivestite-farmacia-dottor-tili-1213791932.jpg?v=1767141587"},{"product_id":"venoruton-1000mg-30-bustine-granulato","title":"Venoruton 1000mg 30 sachets granules","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVENORUTON is indicated in the treatment of symptoms related to venous insufficiency; states of capillary fragility.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eVenoruton 1000 mg powder\u003c\/u\u003e: One sachet contains - Active ingredient: oxerutin 1000 mg. \u003cu\u003eVenoruton 500 mg coated tablets\u003c\/u\u003e: One tablet contains: Active ingredient oxerutin 500 mg. Excipients with known effects: sunset yellow aluminum lake (E 110) (2.68 mg\/tablet). \u003cu\u003eVenoruton 2% gel\u003c\/u\u003e: 100 g of gel contains: Active ingredient oxerutin 2 g. Excipients with known effects: benzalkonium chloride 0.05 mg\/g. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eVenoruton 1000 mg powder\u003c\/u\u003e: mannitol; sodium saccharin; citric acid monohydrate. \u003cu\u003eVenoruton 500 mg coated tablets\u003c\/u\u003e: polyacrylate dispersion 30 percent; talc; magnesium stearate; macrogoli; copovidone; \u003cb\u003esunset yellow aluminum lacquer (E 110)\u003c\/b\u003e; titanium dioxide. \u003cu\u003eVenoruton 2% gel for cutaneous use:\u003c\/u\u003e carbomers; sodium hydroxide; disodium edetate; \u003cb\u003ebenzalkonium chloride\u003c\/b\u003e; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eVenoruton 1000 mg powder\u003c\/u\u003e: 2 to 3 sachets per day, depending on the severity of the symptom. The contents of each sachet of powder should be carefully dissolved in a little water and taken before or during meals, even in venous insufficiency of the hemorrhoidal plexus. \u003cu\u003eVenoruton 500 mg coated tablets\u003c\/u\u003e: 2 - 3 tablets per day. The tablets should be swallowed whole with a little water, without chewing, before or during meals, even in venous insufficiency of the haemorrhoidal plexus. \u003cu\u003eVenoruton 2% gel for cutaneous use\u003c\/u\u003e: apply an adequate quantity of gel both on the area affected by the disorder and on the surrounding areas, 2 times a day (morning and evening). Massage lightly to allow the medicine to penetrate until completely absorbed, that is, until the skin feels dry upon contact with your hands. Do not exceed the recommended doses. Use only for short treatment periods.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePatients suffering from lower limb edema due to heart, kidney or liver disease should not take Venoruton as the effect of Venoruton is not proven in these indications. Pediatric population The use of Venoruton is not recommended in children. \u003cu\u003eVenoruton gel\u003c\/u\u003e: The use, especially if prolonged, of products to be applied to the skin can give rise to sensitization phenomena. In this case you should stop treatment and contact your doctor to institute suitable therapy. \u003cb\u003e \u003ci\u003eImportant information about some excipients\u003c\/i\u003e \u003c\/b\u003e Venoruton 1000 mg powder contains: - sodium saccharin: this medicinal product contains less than 1 mmol (23 mg) sodium per dose, i.e. essentially 'sodium-free'. Venoruton 500 mg film-coated tablets contain the azo coloring agent: - sunset yellow aluminum lake (E 110): may cause allergic reactions. Venoruton gel contains: - benzalkonium chloride: this medicinal product contains 0.391 mg of benzalkonium chloride per dose equivalent to 0.05 mg\/g. Benzalkonium chloride may irritate the skin. If you are breastfeeding, do not apply this medicine to your breasts because your baby may ingest it with his milk.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo date, no specific interaction of oxerutin with other medicinal products has been reported. In vitro data on a possible modulation of CYP3A activity by oxerutin components (quercetin and rutin present in trace amounts) are conflicting. Venoruton gel: no interactions with medicinal products have been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVenoruton oral formulations: \u003cb\u003eSafety profile summary \u003c\/b\u003e Venoruton may in rare cases cause gastrointestinal side effects or skin reactions such as gastrointestinal disorders, flatulence, diarrhoea, abdominal pain, stomach discomfort, dyspepsia, rash, itching or hives. Very rare is the appearance of dizziness, headache, hot flashes, tiredness or hypersensitivity reactions such as anaphylactoid reactions. \u003cb\u003eTable of adverse reactions \u003c\/b\u003e Side effects are listed below by system organ class and frequency. Frequencies are defined as: very common (≥ 1\/10), common (≥ 1\/100 to \u003c 1\/10); uncommon (≥ 1\/1,000 to \u003c 1\/100); rare (≥ 1\/10,000 to \u003c 1,000); very rare (\u003c 1\/10,000), or not known (frequency cannot be estimated from the available data). Within each frequency class, undesirable effects are indicated in order of decreasing seriousness.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Anaphylactoid reactions.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Hypersensitivity reactions\u003c\/p\u003e\n\u003cp\u003eNervous system disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Dizziness.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Headache.\u003c\/p\u003e\n\u003cp\u003eVascular pathologies.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Flushing.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Gastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Flatulence.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Diarrhoea.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Abdominal pain.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Stomach disorders.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Dyspepsia.\u003c\/p\u003e\n\u003cp\u003ePathologies of the skin and subcutaneous tissue.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Rash.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Pruritus.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse reactions: Urticaria.\u003c\/p\u003e\n\u003cp\u003eSystemic pathologies and conditions relating to the administration site.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Tiredness.\u003c\/p\u003e\n\u003cp\u003eVenoruton gel: \u003cb\u003eSafety profile summary\u003c\/b\u003e Venoruton gel is well tolerated. Rare cases of sensitization with the appearance of skin reactions have been observed. These symptoms disappear when treatment is stopped. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo case of overdose has ever been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e The safety of the drug in pregnancy has not been determined, therefore it is not recommended during pregnancy. \u003cu\u003eBreastfeeding\u003c\/u\u003e In animal studies, traces of oxerutin have been found in breast milk. It is assumed that the small quantities of oxerutin that pass into breast milk can be considered to have no clinical relevance for humans. \u003cu\u003eFertility\u003c\/u\u003e Animal studies have shown no effects on fertility after administration of oxerutin.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVenoruton has no or negligible influence on the ability to drive or use machines. In rare cases, tiredness and dizziness have been reported in patients taking the product. Affected patients are advised not to drive or use machinery. Venoruton gel does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Eg","offers":[{"title":"Default Title","offer_id":51131377320263,"sku":"017076074","price":18.24,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/eg-spa-venoruton-1000mg-30-bustine-granulato-farmacia-dottor-tili-1213791844.jpg?v=1767140748"},{"product_id":"emorsan-fleb-14-stick-15-ml-emorroidi","title":"Emorsan Fleb 14 sticks 15 ml hemorrhoids","description":"\u003cp\u003e\n\u003cstrong\u003eEmorsan Fleb 14 sticks 15 ml\u003c\/strong\u003e it's a \u003cstrong\u003especific food supplement to support venous function and the haemorrhoidal plexus\u003c\/strong\u003e, ideal as an adjuvant in moles \u003cstrong\u003eremedies for hemorrhoids\u003c\/strong\u003e and for the well-being of the microcirculation. Its advanced formulation combines ingredients with proven effectiveness such as \u003cstrong\u003ediosmin, quercetin, hesperidin, bromelain and butcher's broom\u003c\/strong\u003e, known for their synergistic action in promoting the \u003cstrong\u003evenous tone\u003c\/strong\u003e, the \u003cstrong\u003elymphatic drainage\u003c\/strong\u003e and the \u003cstrong\u003emicrocirculatory flow\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cp\u003e\nEach stick contains a balanced mix of \u003cstrong\u003ebioflavonoids\u003c\/strong\u003e (diosmin, quercetin, hesperidin) e \u003cstrong\u003eplant extracts\u003c\/strong\u003e such as butcher's broom, which help reduce the feeling of heaviness and discomfort typical of \u003cstrong\u003ehaemorrhoidal pathology\u003c\/strong\u003e. The presence of \u003cstrong\u003ebromelain\u003c\/strong\u003e helps to counteract inflammatory processes, while the\u003cstrong\u003esweet orange\u003c\/strong\u003e It provides a high content of hesperidin, useful for the protection of blood vessels.\n\u003c\/p\u003e\n\u003cp\u003e\n\u003cstrong\u003eEmorsan Fleb stick\u003c\/strong\u003e it is practical to take thanks to the 15 ml single-dose format, perfect for daily use and to guarantee maximum effectiveness of the treatment. Its composition is designed to offer a \u003cstrong\u003eQuick relief from hemorrhoid symptoms\u003c\/strong\u003e and to promote the recovery of normal venous function, proving to be a valid ally in \u003cstrong\u003etreatment of hemorrhoids\u003c\/strong\u003e and in maintaining vascular well-being.\n\u003c\/p\u003e\n\u003cp\u003e\nChoose \u003cstrong\u003eEmorsan Fleb 14 sticks\u003c\/strong\u003e for a \u003cstrong\u003ehemorrhoid supplement\u003c\/strong\u003e complete, effective and easy to take, designed for those looking for a natural and targeted solution for \u003cstrong\u003ewell-being of the hemorrhoidal plexus\u003c\/strong\u003e and venous circulation.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Emorsan Fleb 14 stick 15 ml used for hemorrhoids? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on bioflavonoids (diosmin, quercetin, hesperidin), bromelain and butcher's broom, formulated to promote venous tone, lymphatic drainage and microcirculation functionality; indicated as an adjuvant for the well-being of the hemorrhoidal plexus and to counteract the sensation of heaviness and discomfort.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Emorsan Fleb 14 stick 15 ml for hemorrhoids contain?\u003c\/h3\u003e\u003cp\u003eDemineralised water, sweet orange [Citrus aurantium subsp. sinensis (L.) Engl.] fruits d.e. tit. 60% in hesperidin; thickener: sorbitol; diosmin, quercetin, NFB2 (hydrolyzate of \u003cstrong\u003ecasein\u003c\/strong\u003e - \u003cstrong\u003emilk\u003c\/strong\u003e and derivatives), bromelain 2,500 GDU\/g; acidifier: anhydrous citric acid; preservative: potassium sorbate; butcher's broom (Ruscus aculeatus L.) rhizome d.e. tit. 10% ruscogenin; aromas: pineapple aroma; preservative: sodium benzoate; thickener: xanthan gum; sweetener: sucralose.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Emorsan Fleb 14 stick 15 ml for hemorrhoids contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage contents per daily dose (1 stick pack of 15 ml)\u003c\/strong\u003e\u003cbr\u003eSweet orange dry extract: 833.33 mg\u003cbr\u003ehesperidin intake: 500 mg\u003cbr\u003eDiosmin: 300 mg\u003cbr\u003eQuercetin: 200 mg\u003cbr\u003eBromelain: 80 mg\u003cbr\u003eNFB2 (casein hydrolysate): 100 mg\u003cbr\u003eButcher's broom d.e.: 20 mg\u003cbr\u003eintake in ruscogenin: 2 mg\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Emorsan Fleb 14 stick 15 ml for hemorrhoids?\u003c\/h3\u003e\u003cp\u003eTake one stick-pack per day as is or diluted in still water. Shake before use. Take between meals.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Emorsan Fleb 14 stick 15 ml hemorrhoids?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eAny slight variations in color and taste and the possible formation of precipitates which can be suspended by shaking are linked to the normal variability of the ingredients of natural origin and are not an indication of an alteration in the quality of the product.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Emorsan Fleb 14 stick 15 ml for hemorrhoids stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, protected from light.\u003cbr\u003eValidity with intact packaging: 36 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Emorsan Fleb 14 stick 15 ml hemorrhoids?\u003c\/h3\u003e\u003cp\u003ePack of 14 stick packs of 15 ml.\u003cbr\u003eNet content: 210 ml.\u003c\/p\u003e","brand":"Depofarma","offers":[{"title":"Default Title","offer_id":51749050974535,"sku":"924911478","price":18.34,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/depofarma-spa-emorsan-fleb-14-stick-15-ml-emorroidi-farmacia-dottor-tili-1213791259.jpg?v=1767158069"},{"product_id":"ciambella-gonfiabile-in-gomma-40-cm-antidecubito","title":"40cm inflatable rubber ring for bedsore relief","description":"\u003cp\u003e\nThe \u003cstrong\u003eInflatable rubber donut 40 cm anti-decubitus\u003c\/strong\u003e it's a \u003cstrong\u003eanti-decubitus device\u003c\/strong\u003e designed to offer effective and comfortable support to those who need to prevent or relieve pain \u003cstrong\u003ebedsores\u003c\/strong\u003e during long stays in bed or sitting. Made in \u003cstrong\u003eresistant rubber\u003c\/strong\u003e and latex-free, this one \u003cstrong\u003eanti-decubitus donut\u003c\/strong\u003e guarantees excellent distribution of body weight, reducing pressure on the most delicate areas and promoting patient comfort. \n\u003c\/p\u003e\n\u003cp\u003e\nThanks to his \u003cstrong\u003ediameter of 40 cm\u003c\/strong\u003e, the donut adapts perfectly to different types of seating, making it ideal for both domestic use and in hospital or healthcare settings. The \u003cstrong\u003einflatable pillow\u003c\/strong\u003e It is easy to carry and use, offering a practical solution for \u003cstrong\u003eprevention of bedsores\u003c\/strong\u003e and support during post-operative convalescence, such as after haemorrhoidectomy operations. \n\u003c\/p\u003e\n\u003cp\u003e\nThe \u003cstrong\u003erubber donut\u003c\/strong\u003e it is designed to support up to approximately 150 kg, ensuring robustness and durability over time. The high quality material allows for easy cleaning and sanitisation, while the possibility of covering it with a cotton cover further increases comfort during use. Choose the \u003cstrong\u003einflatable anti-decubitus donut\u003c\/strong\u003e for a \u003cstrong\u003eseat support\u003c\/strong\u003e reliable, practical and safe, designed for the well-being and health of the person.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is the 40 cm anti-decubitus inflatable rubber donut used? What is it for?\u003c\/h3\u003e\u003cp\u003eInflatable rubber donut, latex-free, indicated for the prevention and alleviation of bedsores during long stays in bed or in a sitting position; promotes a uniform distribution of body weight, also proving useful during post-operative convalescence.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use the 40 cm anti-decubitus inflatable rubber donut?\u003c\/h3\u003e\u003cp\u003eCan be used, exclusively when prescribed by the doctor, in the following cases: after haemorrhoidectomy, long stays in bed or on commodes.\u003cbr\u003eBefore use, consult a specialist doctor. Before using the device, make sure it is in good condition, free of cracks, creases and holes. Taking care to carefully close the inflation valve, carefully clean the external surface of the device using warm water and neutral soap. Dry, paying particular attention to the inflation valve. Proceed with moderate inflation. Overinflation can cause breakage and\/or irreversible damage. For inflation it is possible to use the special pump (ref. 937414706) not included in the package, but available on request. During use it is advisable to cover the donut with a cotton cover.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of the 40 cm anti-decubitus inflatable rubber donut?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use in direct contact with the skin and\/or on damaged and compromised surfaces;\u003cbr\u003eDo not fold during or after use;\u003cbr\u003eAvoid contact with sharp and\/or pungent objects or, in general, with pointed and angular objects;\u003cbr\u003eAvoid contact with fire and\/or incandescent objects;\u003cbr\u003eFill only with air, do not fill with liquids or other substances;\u003cbr\u003eChildren under the age of 12, disabled or disabled people cannot use the device alone, but must be assisted\/supervised by other people;\u003cbr\u003eIf the device is damaged or compromised, replace it;\u003cbr\u003eAny use other than that described is to be considered improper.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the size of the 40cm anti-decubitus inflatable rubber donut?\u003c\/h3\u003e\u003cp\u003eMaximum capacity: approximately 150 kg.\u003cbr\u003eAvailable with circumference:\u003cbr\u003e- 40cm,\u003cbr\u003e- 43 cm.\u003c\/p\u003e","brand":"Farmacare","offers":[{"title":"Default Title","offer_id":51821894959431,"sku":"901794370","price":16.44,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/farmacare-srl-ciambella-gonfiabile-in-gomma-40-cm-antidecubito-farmacia-dottor-tili-1213790848.jpg?v=1767155208"},{"product_id":"levorag-emulgel-20-tubetti-3-5-ml-emorroidi","title":"Levorag emulgel 20 tubes 3.5 ml hemorrhoids","description":"\u003cp\u003e\n\u003cstrong\u003eLevorag emulgel 20 tubes 3.5 ml\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e specifically formulated for \u003cstrong\u003etreatment of hemorrhoids\u003c\/strong\u003e and of \u003cstrong\u003eanal fissures\u003c\/strong\u003e. Thanks to its innovativeness \u003cstrong\u003eformulation based on principles of natural origin\u003c\/strong\u003e, Levorag emulgel offers action \u003cstrong\u003eemollient, lubricating, film-forming, soothing and protective\u003c\/strong\u003e on the anal area, contributing to \u003cstrong\u003eQuickly relieve symptoms such as anal pain and itching\u003c\/strong\u003e. Its film-forming action creates a protective barrier that \u003cstrong\u003epreserves the treated area from the bacterial microenvironment\u003c\/strong\u003e, favoring the \u003cstrong\u003erepair of the mucosal epithelium\u003c\/strong\u003e and the restoration of optimal physiological conditions.\n\u003c\/p\u003e\n\u003cp\u003e\nThe \u003cstrong\u003eoily part of the formulation\u003c\/strong\u003e facilitates \u003cstrong\u003elubrication of the anal area\u003c\/strong\u003e, making evacuation easier and preventing the formation of further microlesions. The antioxidant and protective action of Levorag emulgel contributes to \u003cstrong\u003ereduce inflammation\u003c\/strong\u003e and others \u003cstrong\u003einhibit the progression of tissue damage\u003c\/strong\u003e, ensuring a \u003cstrong\u003eprolonged well-being\u003c\/strong\u003e and a feeling of immediate relief. The product is packaged in \u003cstrong\u003epractical single-dose tubes with applicator\u003c\/strong\u003e, which ensure a hygienic and precise application, ideal for\u003cstrong\u003etopical use\u003c\/strong\u003e daily.\n\u003c\/p\u003e\n\u003cp\u003e\nLevorag emulgel is suitable for those looking for a \u003cstrong\u003eEffective cream for hemorrhoids and anal wounds\u003c\/strong\u003e, capable of \u003cstrong\u003erelieve the symptoms of hemorrhoids\u003c\/strong\u003e and promote the healing of fissures. Its formula contains ingredients such as \u003cstrong\u003esweet almond oil, borage oil, mallow extract, panthenol, calendula extract and liquorice extract\u003c\/strong\u003e, known for their soothing and repairing properties. Choose Levorag emulgel for one \u003cstrong\u003ecomplete protection of the anal area\u003c\/strong\u003e and a \u003cstrong\u003etargeted treatment of hemorrhoid symptoms\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Levorag emulgel 20 tubes 3.5 ml used for hemorrhoids? What is it for?\u003c\/h3\u003e\u003cp\u003eLevorag emulgel 20 tubes 3.5 ml is a medical device specifically formulated for the treatment of hemorrhoids and anal fissures.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Levorag emulgel 20 tubes 3.5 ml for hemorrhoids contain?\u003c\/h3\u003e\u003cp\u003eAqua, Dimethicone, Glycerin, Prunus Amygdalus Dulcis Oil, Phenyl Trimethicone, Borago Officinalis Seed Oil, Malva Sylvestris Extract, Panthenol, Dextrin, Hydrolyzed Hibiscus Esculentus Extract, Phenoxyethanol, Glyceryl Stearate, Cetyl Alcohol, PEG-75 Stearate, Acrylated\/C10-30 Alkyl Acrylate Crosspolymer, Triethanolamine, Tocopherol, Caprylyl Glycol, 1,2-Hexanediol, Calendula Officinalis Extract, Maltodextrin, Glycyrrhiza Glabra Extract, Ceteth-20, Steareth-20, Ethylhexylglycerin, Sodium Carboxymethyl Beta-Glucan, Trisodium Ethylenediamine Disuccinate, Tropolone, Aspartic Acidm Sodium Chloride, Sodium Bromide.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Levorag emulgel 20 tubes 3.5 ml for hemorrhoids?\u003c\/h3\u003e\u003cp\u003eThoroughly cleanse the area to be treated, we recommend the use of Deliclin sanitizing wipes.\u003cbr\u003eRemove the cap located at the end of the applicator. Grasp the tube and gently insert the applicator into the anal orifice, avoiding inserting the cannula completely, press the reservoir fully to dispense the entire contents of the tube.\u003cbr\u003eA single-dose container is used for one application. Apply two single doses per day, for at least 20 consecutive days, unless otherwise indicated by the doctor, preferably morning and evening, possibly after the evacuation of stool.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Levorag emulgel 20 tubes 3.5 ml hemorrhoids?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eIn case of unwanted reactions, stop treatment and consult your doctor.\u003cbr\u003eAvoid using disinfectants because they negatively affect the healing process.\u003cbr\u003eThere are currently no known contraindications to the use of the components contained in Levorag-EmulGel during pregnancy or breastfeeding. As a precaution, its use is recommended under direct medical supervision.\u003cbr\u003eAvoid contact with eyes.\u003cbr\u003eKeep out of reach of children.\u003cbr\u003eIf symptoms persist after treatment, it is advisable to consult your doctor.\u003cbr\u003eDo not use if the original packaging appears damaged or opened.\u003cbr\u003eDo not use in case of proven hypersensitivity to one or more components of the product.\u003cbr\u003eIf unexpected reactions occur, stop treatment and contact your doctor.\u003cbr\u003eDo not apply the device to areas treated simultaneously with other ointments or disinfectants. Improper use of the device can lead to delayed tissue repair, preventing the physiological healing process.\u003cbr\u003eUse is not recommended on patients suffering from:\u003cbr\u003e- expulsive constipation with the need for prolonged straining or manual maneuvers during evacuation;\u003cbr\u003e- presence of fecal incontinence.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Levorag emulgel 20 tubes 3.5 ml stored for hemorrhoids?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, away from heat sources.\u003cbr\u003eThe expiry date is indicated on the box and on each single dose, do not use the product beyond the indicated date.\u003cbr\u003eValidity with intact packaging: 24 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Levorag emulgel 20 tubes 3.5 ml hemorrhoids?\u003c\/h3\u003e\u003cp\u003ePack of 20 single-dose tubes with 3.5 ml applicator.\u003c\/p\u003e","brand":"Thd","offers":[{"title":"Default Title","offer_id":51821904101703,"sku":"931382764","price":36.96,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/thd-levorag-emulgel-20-tubetti-3-5-ml-emorroidi-farmacia-dottor-tili-1258975872.jpg?v=1789558929"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/collections\/Frame_53_41.svg?v=1784274123","url":"https:\/\/www.dottortili.com\/en\/collections\/drugs-and-treatments-for-varicose-veins-and-hemorrhoids.oembed?page=2","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}